NYSE:LHHealthcare
Labcorp (LH): Reassessing Valuation After Reduced Growth Outlook for Contract Research Unit
Labcorp Holdings (LH) just beat earnings expectations, but the stock is reacting more to management’s cautious tone after cutting revenue growth targets for its contract research unit and trimming its full year outlook.
See our latest analysis for Labcorp Holdings.
At around $264.18 per share, Labcorp’s recent weakness, reflected in a roughly 5 percent 3 month share price return, contrasts with a solid 5 year total shareholder return of about 57 percent. This suggests momentum has cooled as...